SION (STOCKS)
Sionna Therapeutics, Inc. Common Stock
$41.770000
+3.880000 (+10.24%)
Prev close: $37.890000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Cloonan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,877.32M
- Employees
- 48
- P/E (TTM)
- -24.62
- P/B (TTM)
- 5.52
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
1
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.46 | $-0.55 | +0.0894 | +16.27% |
|
Sep 2025 (Q3)
|
$-0.46 | $-0.49 | +0.0340 | +6.88% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.57 | +0.1561 | +27.57% |
|
Mar 2025 (Q1)
|
$-0.62 | $-0.46 | -0.1635 | -35.82% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $13.71M |
| Operating Expenses | $88.98M |
| Research and Development | $60.26M |
| Other Operating Expenses | $28.72M |
| Operating Income/Loss | -$88.98M |
| Income/Loss From Continuing Operations After Tax | -$75.27M |
| Income/Loss From Continuing Operations Before Tax | -$75.27M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$75.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$75.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$75.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.88 |
| Diluted Earnings Per Share | -$1.88 |
| Basic Average Shares | 39,962,163 |
| Diluted Average Shares | 39,962,163 |
| Assets | $325.95M |
| Current Assets | $241.42M |
| Noncurrent Assets | $84.53M |
| Fixed Assets | $2.23M |
| Other Non-current Assets | $82.31M |
| Liabilities | $19.12M |
| Current Liabilities | $11.71M |
| Wages | $4.74M |
| Other Current Liabilities | $6.97M |
| Noncurrent Liabilities | $7.41M |
| Equity | $306.83M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $306.83M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $325.95M |
| Net Cash Flow From Operating Activities | -$66.30M |
| Net Cash Flow From Operating Activities, Continuing | -$66.30M |
| Net Cash Flow From Investing Activities | -$118.75M |
| Net Cash Flow From Investing Activities, Continuing | -$118.75M |
| Net Cash Flow From Financing Activities | $205.71M |
| Net Cash Flow From Financing Activities, Continuing | $205.71M |
| Net Cash Flow | $20.66M |
| Net Cash Flow, Continuing | $20.66M |
| Comprehensive Income/Loss | -$75.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$75.10M |
| Other Comprehensive Income/Loss | $172.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $172.00K |